1-5 of 5
Giuseppe Avola
Close
Sort by
Journal Articles

High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality

Giuseppe Milone, MDPhD, Viviana Frontini, Alessandra Cupri, Salvatore Leotta, Annalia DiMarco, Carla Consoli, Luca Scalise, Giuseppe Sapienza, Gaetano Moschetti, Giuseppe Avola, Andrea Spadaro, AnnaElisa Marchese, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4497.
https://doi.org/10.1182/blood.V130.Suppl_1.4497.4497
Published: 2017
Journal Articles

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Giuseppe Milone, MD, Massimo Martino, Annalia Di Marco, BS, Salvatore Leotta, MD, Andrea Spadaro, MD, Mara Morelli, MD, Giuseppe Avola, Maria Grazia Camuglia, Alessandra Cupri, MD, Valentina Zammit, MD, Potito Rosario Scalzulli, MD, Calafiore Valeria, MD, Attilio Olivieri, MD, Giovanni Tripepi, PhD
Journal: Blood
Blood (2015) 126 (23): 4305.
https://doi.org/10.1182/blood.V126.23.4305.4305
Published: 2015
Journal Articles

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Giuseppe Milone, MD, Giuseppe Avola, Maria Grazia Camuglia, Salvatore Leotta, MD, Alessandra Cupri, Andrea Spadaro, MD, Giovanni Tripepi, MD
Journal: Blood
Blood (2014) 124 (21): 1160.
https://doi.org/10.1182/blood.V124.21.1160.1160
Published: 2014
Journal Articles

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Giuseppe Milone, Salvatore Leotta, Giuseppe Avola, Massimo Poidomani, Maria Grazia Camuglia and Andrea Spadaro
Journal: Blood
Blood (2010) 116 (21): 4563.
https://doi.org/10.1182/blood.V116.21.4563.4563
Published: 2010
Journal Articles

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Giuseppe Milone, MD, Benedetto Farsaci, MD, Giuseppe Avola, BD, Salvatore Mercurio, BD, Aurora Strano, BD, Maria Grazia Camuglia, BD, Valeria Pinto, MD, Antonella Privitera, BD, Salvatore Leotta, MD, Massimo Poidomani, MD, Stefania Coppoletta, MD, Elisa Mauro, MD, Pamela Murgano, MD, Katia Battiato, MD, Andrea Spataro, MD, Anna Triolo, MD, Rosario Giustolisi, MD
Journal: Blood
Blood (2007) 110 (11): 2849.
https://doi.org/10.1182/blood.V110.11.2849.2849
Published: 2007